Interpace Diagnostics, SelectHealth Sign Patient Coverage Agreement for Thyroid Cancer Tests

Interpace Diagnostics announced that it has signed an agreement with SelectHealth/Intermountain Healthcare to offer its thyroid cancer detection assays to SelectHealth’s members in Utah and Idaho. 

In addition, Interpace said it will act as an in-network laboratory for these services to SelectHealth’s members.

Source: https://www.genomeweb.com/business-news/interpace-diagnostics-selecthealth-sign-patient-coverage-agreement-thyroid-cancer